John Bender - Aspira Womens President
| AWH Stock | USD 3.40 0.01 0.29% |
President
Mr. John R. Bender serves as Chief Executive Officer Reinsurance of Allied World Reinsurance Management Company of the Company. He was the Chief Executive Officer, Reinsurance of Allied World Reinsurance Management Company since August 2014 and oversees our reinsurance platform on a global basis. From February 2012 to August 2014, he served as the President of Allied World Reinsurance Management Company. From August 2009 to February 2012, he served as the President and Chief Operating Officer of Allied World Reinsurance Company, one of our subsidiaries. He joined us in November 2007 as the Chief Operating Officer of Allied World Reinsurance Company. From November 2007 through November 2011, Mr. Bender was responsible for establishing and expanding the companys U.S. reinsurance platform and for overseeing its daytoday operations. Since December 2011, Mr. Bender has assumed responsibility for providing strategic leadership and executing business strategies for our global reinsurance operations. Prior to joining us, Mr. Bender held several senior management positions at Platinum Underwriters Holdings, Ltd., including Chief Underwriting Officer, Casualty from November 2005 to October 2007 and Senior Vice President, Commercial Liability Products from October 2002 to November 2005. From 1989 to October 2002, he held numerous claims and underwriting positions with St. Paul Reinsurance Management Company. since 2014.
| Age | 51 |
| Tenure | 10 years |
| Address | Building III, Austin, TX, United States, 78738 |
| Phone | 512 519 0400 |
| Web | https://aspirawh.com |
Aspira Womens Management Efficiency
The company has Return on Asset of (0.997) % which means that on every $100 spent on assets, it lost $0.997. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (7.2345) %, meaning that it generated no profit with money invested by stockholders. Aspira Womens' management efficiency ratios could be used to measure how well Aspira Womens manages its routine affairs as well as how well it operates its assets and liabilities. The Aspira Womens' current Return On Equity is estimated to increase to 7.41, while Return On Tangible Assets are forecasted to increase to (2.53). As of now, Aspira Womens' Fixed Asset Turnover is increasing as compared to previous years. The Aspira Womens' current Asset Turnover is estimated to increase to 1.53, while Total Assets are projected to decrease to under 5.9 M.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Michael Rutz | Sotera Health Co | 53 | |
| Veronica Foley | Prenetics Global | N/A | |
| Ronald Bruehlman | IQVIA Holdings | 63 | |
| Wendy Stewart | IQVIA Holdings | N/A | |
| Kevin Knightly | IQVIA Holdings | 63 | |
| Erlinger Sherbet | IQVIA Holdings | 51 | |
| Michael McDonnell | IQVIA Holdings | 55 | |
| Jon Resnick | IQVIA Holdings | N/A | |
| Michael Murdock | RadNet Inc | 62 | |
| Darcy Falardeau | Prenetics Global | N/A | |
| Richard III | IQVIA Holdings | 61 | |
| Todd Skulte | RadNet Inc | 55 | |
| Darren Ruhr | Prenetics Global | N/A | |
| Richard Staub | IQVIA Holdings | 54 | |
| Niels Espeland | Prenetics Global | N/A | |
| Derek Bomar | RadNet Inc | 46 | |
| Samantha Kwok | Prenetics Global | N/A | |
| Eric Sherbet | IQVIA Holdings | 60 | |
| Rob Kotchie | IQVIA Holdings | N/A | |
| Gene Stahl | Prenetics Global | N/A | |
| Kristen Oelschlager | Castle Biosciences | N/A | |
Management Performance
| Return On Equity | -7.23 | ||||
| Return On Asset | -1.0 |
Aspira Womens Health Leadership Team
Elected by the shareholders, the Aspira Womens' board of directors comprises two types of representatives: Aspira Womens inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aspira. The board's role is to monitor Aspira Womens' management team and ensure that shareholders' interests are well served. Aspira Womens' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aspira Womens' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Wesley Dupont, Executive Vice President General Counsel | ||
| Susan Chmieleski, President of Allied World North American Healthcare | ||
| Emily Granger, Director Marketing | ||
| Robert CPA, Chief Officer | ||
| Sarah Doran, IR Contact Officer | ||
| Michael Newton, VP Commercial | ||
| Marlene McLennan, Interim Officer | ||
| James Duffy, Independent Director | ||
| John Gauthier, Executive Vice President Chief Investment Officer; President of Allied World Financial Services, Inc. and Allied World Financial Services, Ltd | ||
| Jody Berry, Chief Officer | ||
| Barbara Alexander, Independent Director | ||
| Patricia Guinn, Director | ||
| Nicole CPA, CEO President | ||
| Fiona Luck, Director | ||
| Gregory Richard, Sr Devel | ||
| Valerie Palmieri, Ex Chairwoman | ||
| Bart Friedman, Lead Independent Vice Chairman of the Board | ||
| Louis Iglesias, President of North America for Allied World Assurance Company (US) Inc and President of North America for Allied World National Assurance Company | ||
| Scott Carmilani, Chairman, CEO and President and Chairperson of Executive Committee | ||
| Julian James, President of Allied World Assurance Company (Europe) Limited | ||
| John McElroy, COO | ||
| Giuseppe Montefinese, IR Contact Officer | ||
| Michelle Snider, Senior Operations | ||
| Ryan MD, Chief Officer | ||
| Torsten Hombeck, Senior CFO | ||
| Eric Schwartz, Independent Director | ||
| Marshall Grossack, Executive Vice President Chief Actuary | ||
| Frank DOrazio, President of Underwriting and Global Risk | ||
| Dale Chow, Senior Vice President - Professional Lines of Allied World Bermuda | ||
| Patrick SaintAignan, Independent Director | ||
| Sean Rowe, VP Technology | ||
| Samuel Weinhoff, Independent Director | ||
| Kent Ziegler, Senior Vice President - Finance, Chief Accounting Officer | ||
| John Bender, President of Allied World Reinsurance Management Company | ||
| Minh Merchant, General Secretary | ||
| Thomas Bradley, CFO and Executive VP | ||
| Charles MD, Interim Officer | ||
| MD JD, President |
Aspira Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aspira Womens a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -7.23 | ||||
| Return On Asset | -1.0 | ||||
| Profit Margin | (1.82) % | ||||
| Operating Margin | (1.94) % | ||||
| Current Valuation | 43.46 M | ||||
| Shares Outstanding | 12.34 M | ||||
| Shares Owned By Insiders | 38.84 % | ||||
| Shares Owned By Institutions | 9.09 % | ||||
| Number Of Shares Shorted | 134.16 K | ||||
| Price To Earning | 16.82 X |
Pair Trading with Aspira Womens
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aspira Womens position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aspira Womens will appreciate offsetting losses from the drop in the long position's value.Moving against Aspira Stock
| 0.85 | AGTI | Agiliti Financial Report 14th of May 2024 | PairCorr |
| 0.85 | ELEV | Elevation Oncology Earnings Call Next Week | PairCorr |
| 0.81 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
| 0.8 | DSGN | Design Therapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.72 | NXL | Nexalin Technology | PairCorr |
The ability to find closely correlated positions to Aspira Womens could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aspira Womens when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aspira Womens - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aspira Womens Health to buy it.
The correlation of Aspira Womens is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aspira Womens moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aspira Womens Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aspira Womens can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aspira Womens Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Aspira Stock analysis
When running Aspira Womens' price analysis, check to measure Aspira Womens' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspira Womens is operating at the current time. Most of Aspira Womens' value examination focuses on studying past and present price action to predict the probability of Aspira Womens' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aspira Womens' price. Additionally, you may evaluate how the addition of Aspira Womens to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Aspira Womens' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womens. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womens listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.81) | Revenue Per Share 0.991 | Quarterly Revenue Growth (0.01) | Return On Assets (1.00) | Return On Equity (7.23) |
The market value of Aspira Womens Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womens' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womens' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womens' market value can be influenced by many factors that don't directly affect Aspira Womens' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womens' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aspira Womens is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womens' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.